申请人:Eli Lilly and Company
公开号:US09073856B2
公开(公告)日:2015-07-07
The present invention provides compounds of Formula I or a pharmaceutical salt thereof, where the variables for R1, R2, and R3 are as described herein; methods of treating a condition such as hypertriglyceridemia; and processes for preparing the compounds.
本发明提供了I式化合物或其药物盐,其中R1,R2和R3的变量如此处所述;用于治疗高甘油三酯血症等疾病的方法;以及制备这些化合物的过程。